在牛皮中发生重大心血管事件后治疗的持续性:一项回顾性队列研究,比较生物,系统和光疗
Hyun Keun Ahn1, Sohee Oh2, Hyun-Sun Yoon3,4
1Department of Dermatology, Seoul National University Hospital, Seoul, Korea.
The Journal of dermatology
|September 8, 2025
概括
与其他治疗相比,接受生物疗法的牛皮患者在心血管事件后表现出更高的治疗持久性. 这表明,对于心脏事件后的高风险牛皮患者来说,生物药物被视为更安全.
科学领域:
- 皮肤病学和心脏病学
- 药物监督 药物监督 药物监督
- 医疗保健服务研究 医疗服务研究
背景情况:
- 牛皮患者心血管风险增加.
- 在发生重大心血管不良事件 (MACE) 后,缺乏继续治疗牛皮的指导方针.
研究的目的:
- 为了检查MACE后的牛皮治疗修改.
- 为了比较MACE后不同牛皮治疗的治疗持久性.
主要方法:
- 使用韩国医疗保险数据 (2008-2021) 进行的回顾性队列研究.
- 根据治疗方法对患者进行分类:生物药物,非生物系统药物 (环素,甲铁酸盐) 和光疗.
- 在MACE后3个月内使用多变量逻辑回归评估治疗持久性.
主要成果:
- 生物药物治疗持久性显著高 (79.7%),而非生物药物 (46.9%) 和光疗 (47.0%) 持久性明显高.
- 生物药物与较高的持久性强烈相关,而不是环素,甲醇和光疗.
- 在所有组中,改变治疗的频率很少 (0.8%-1.9%).
结论:
- 在牛皮患者中,生物疗法更有可能在心血管事件后继续使用.
- 研究结果表明,在这种高风险人群中,生物药物被认为更安全.
- 强调需要基于证据的指导方针,关于牛皮治疗心脏事件后.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
506
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
506
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
466
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
466
Rheumatic Heart Disease III: Medical Management
290
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
290
Atherosclerosis III: Management
322
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
322
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
571
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
571
Changes in Skin Color: Clinical Perspectives
3.3K
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
3.3K


